These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

924 related items for PubMed ID: 15161039

  • 1. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A.
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [Abstract] [Full Text] [Related]

  • 2. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line.
    Ferreira MJ, Gyémánt N, Madureira AM, Tanaka M, Koós K, Didziapetris R, Molnár J.
    Anticancer Res; 2005; 25(6B):4173-8. PubMed ID: 16309213
    [Abstract] [Full Text] [Related]

  • 3. Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids.
    Molnár J, Gyémánt N, Mucsi I, Molnár A, Szabó M, Körtvélyesi T, Varga A, Molnár P, Tóth G.
    In Vivo; 2004; 18(2):237-44. PubMed ID: 15113052
    [Abstract] [Full Text] [Related]

  • 4. In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells.
    Gyémánt N, Tanaka M, Antus S, Hohmann J, Csuka O, Mándoky L, Molnár J.
    In Vivo; 2005; 19(2):367-74. PubMed ID: 15796199
    [Abstract] [Full Text] [Related]

  • 5. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of cycloartanes on reversal of multidrug resistance and apoptosis induction on mouse lymphoma cells.
    Madureira AM, Spengler G, Molnár A, Varga A, Molnár J, Abreu PM, Ferreira MJ.
    Anticancer Res; 2004 May; 24(2B):859-64. PubMed ID: 15161038
    [Abstract] [Full Text] [Related]

  • 8. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
    Gan HZ, Zhang GZ, Zhao JS, Zhang FC, Bu LS, Yang SJ, Piao SL, Du ZW, Gao S, Zheng DM.
    Chin Med J (Engl); 2005 Jun 05; 118(11):893-902. PubMed ID: 15978189
    [Abstract] [Full Text] [Related]

  • 9. Induction of apoptosis and necrosis by resistance modifiers benzazoles and benzoxazines on tumour cell line mouse lymphoma L5718 Mdr+cells.
    Varga A, Aki-Sener E, Yalcin I, Temiz-Arpaci O, Tekiner-Gulbas B, Cherepnev G, Molnar J.
    In Vivo; 2005 Jun 05; 19(6):1087-91. PubMed ID: 16277027
    [Abstract] [Full Text] [Related]

  • 10. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
    Ding L, Chen XP, Zhang ZW, Wang H, Cao B, Wang ZH, Li CL.
    Zhonghua Wai Ke Za Zhi; 2005 Oct 01; 43(19):1248-53. PubMed ID: 16271222
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones.
    Ferreira MJ, Gyémánt N, Madureira AM, Molnár J.
    Anticancer Res; 2005 Oct 01; 25(5):3259-62. PubMed ID: 16101136
    [Abstract] [Full Text] [Related]

  • 12. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y, Qian F, Wei D, Liu J.
    J Pharm Pharmacol; 2004 Oct 01; 56(10):1307-14. PubMed ID: 15482646
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids.
    Gyémánt N, Tanaka M, Molnár P, Deli J, Mándoky L, Molnár J.
    Anticancer Res; 2006 Oct 01; 26(1A):367-74. PubMed ID: 16475720
    [Abstract] [Full Text] [Related]

  • 15. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists.
    Fu J, Chen Z, Cen J, Ruan C.
    Chin Med J (Engl); 2000 Mar 01; 113(3):228-31. PubMed ID: 11775252
    [Abstract] [Full Text] [Related]

  • 16. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB, Yan ML, Gong JP, Xia RP, Liu LX, Li N, Lu SC, Zhang JG, Zeng DB, Xie JG, Yang JY, Yan LN.
    Chin Med J (Engl); 2007 Apr 20; 120(8):703-7. PubMed ID: 17517188
    [Abstract] [Full Text] [Related]

  • 17. MDR-reversal activity of chalcones.
    Ivanova A, Batovska D, Engi H, Parushev S, Ocsovszki I, Kostova I, Molnar J.
    In Vivo; 2008 Apr 20; 22(3):379-84. PubMed ID: 18610751
    [Abstract] [Full Text] [Related]

  • 18. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 20; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 19. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
    Ratnasinghe D, Daschner PJ, Anver MR, Kasprzak BH, Taylor PR, Yeh GC, Tangrea JA.
    Anticancer Res; 2001 Nov 20; 21(3C):2141-7. PubMed ID: 11501838
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.